Patient P-02195

Synthetic patientMETA-24 · Day 98 · 55–64 · F · baseline S11Steering view · 3D Open companion preview

Therapy response

Stable

Tolerance

Improving

GI state

Improving

Inflammatory state

Improving

Nutritional resilience

Favorable

Discontinuation risk

11%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S11
Day 10 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 10.

Primary contributors, last 14 days

Inflammatory activity-11
Toxicity-11
GI instability-7
Treatment adherence+6
Nutritional resilience+3

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

58 min

stable · -1.4 vs previous 14 d

Sleep duration

Wearable

8.1 h

stable · -0.1 vs previous 14 d

Energy level

Daily log

6.6/10

stable · -0.1 vs previous 14 d

Steps

Wearable

6,719

worsening · -313 vs previous 14 d

GI burden

Companion

14.9/100

improving · -3.3 vs previous 14 d

Adherence

Companion

91.3 %

improving · +7.2 vs previous 14 d

Sleep quality

Wearable

60.6/100

stable · +0.3 vs previous 14 d

Glucose, CGM daily mean

CGM

129 mg/dL

stable · -3.4 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 79 from the failing basin, 20 from restoration.

Good elements to keep

Butyrate producers intact
hidden · steering +7.5
Protein (supports)
perturbation · steering +5.1
Daily walks resumed
perturbation · steering +3.3
Dietary fat load (supports)
perturbation · steering +3.1
Protein
supporter · GI -2.8 next day
Dietary fat load
supporter · GI -1.9 next day

Main detractors to watch

FUT2 non-secretor
hidden · steering -10.6
Histamine load
perturbation · steering -6.6
Alcohol
perturbation · steering -4.3
Poor-sleep week
perturbation · steering -3
Histamine load
detractor · GI +4 next day
Alcohol
detractor · GI +2.5 next day

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Histamine load
+4detractor · 95%
Protein
-2.8supporter · 95%
Alcohol
+2.5detractor · 65%
Dietary fat load
-1.9supporter · 66%
Simple carbohydrates
-1.6no signal · 37%
Insoluble fibre
+0.5no signal · 15%
Caffeine
+0.4no signal · 15%
Ultra-processed food
+0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Mucosal barrier integrity ↓30
- DNAFUT2 non-secretor lowers mucosal fucosylation
Autonomic recovery ↓25
- WearableResting HR 77 bpm

DNA

Fictional pharmacogenomic panel

FUT2 rs601338 AA (non-secretor)
Reduced mucosal fucosylation
CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 4.4 · butyrate capacity 75/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisNormal
Bifidobacterium longumNormal
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 51 ms
Sleep: 7.9 h
Steps: 6,536
Resting HR: 75 bpm

Daily log: GI score 15, nutritional resilience 62, adherence 91.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02620	52%	S01	HY-01	improved	64
P-02082	48%	S12	NP-02	improved	53
P-02462	48%	S12	DT-01	improved	65
P-02518	46%	S17	DT-01	improved	68
P-02698	45%	S06	ME-01	improved	71
P-02064	44%	S04	SC-12	improved	57
P-02441	44%	S11	SC-12	improved	67
P-02147	43%	S13	GI-04	improved	58
P-02235	43%	S14	DT-01	improved	50
P-02303	43%	S15	GI-04	improved	48
P-02538	43%	S02	GI-04	improved	59
P-02645	43%	S02	HY-01	improved	56